ORYZON Announces Topline Results from Phase IIb PORTICO
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th...
Source: globenewswire.com
Global Statistical Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Statistical Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Statistical Test Today - Breaking & Trending Today
ORYZON Announces Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline Personality Disorder (BPD)
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT.An executive summary of the data to be presented at the ...
Source: businessinsider.com
Athira Pharma, Inc. Completes Enrollment of Phase 2/3 Lift-AD Clinical Trial of Fosgonimeton in Mild-To-Moderate Alzheimer's Disease
Athira Pharma, Inc. announced completion of enrollment in the Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer's disease. Fosgonimeton is a...
Source: marketscreener.com
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease -January 03, 2024 at 07:02 am EST
Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation and potential clinically meaningful activity of...
Source: marketscreener.com
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative...
Source: marketscreener.com